Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000226074 | SCV000286034 | likely benign | Rhabdoid tumor predisposition syndrome 2 | 2024-01-30 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000302262 | SCV000410489 | uncertain significance | Coffin-Siris syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000575056 | SCV000664052 | likely benign | Hereditary cancer-predisposing syndrome | 2015-06-28 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001594880 | SCV001829610 | likely benign | not provided | 2020-02-13 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001808613 | SCV002056187 | likely benign | Intellectual disability, autosomal dominant 16 | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000575056 | SCV002532865 | likely benign | Hereditary cancer-predisposing syndrome | 2021-08-17 | criteria provided, single submitter | curation | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV001594880 | SCV004220415 | likely benign | not provided | 2022-09-13 | criteria provided, single submitter | clinical testing |